Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lotriga
- Development stage
- Unknown
- Lead developer
- Takeda
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Lotriga** is a prescription omega-3-derived drug containing highly concentrated and purified ethyl esters of eicosapentaenoic acid (EPA-E) and docosahexaenoic acid (DHA-E), specifically omega-3-acid ethyl esters 90. Developed by Pronova BioPharma and exclusively licensed to Takeda Pharmaceutical for Japan, it lowers triglycerides in patients with hyperlipidemia and hypertriglyceridemia. Administered orally as 2g granular capsules once daily after meals (up to 4g/day), Phase 3 trials in Japan showed it equivalent or superior to EPA monotherapy in triglyceride reduction, with a comparable safety profile including diarrhea as the main ADR.[1][2][3][5]
- Brand names
- Lotriga
- Other names
- Omega-3 Fatty Acid Ethyl Granular Capsules 2g TAKEDA TEVAOmega3 Fatty Acid Ethyl Granular Capsules 2g TAKEDA TEVAOmega 3 Fatty Acid Ethyl Granular Capsules 2g TAKEDA TEVA
02
Targets
VNUT (Vesicular nucleotide transporter)PPARA (Peroxisome proliferator-activated receptor alpha)
Beyond the preview
Go deeper on Lotriga.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lotriga.